Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Find Which Dividend Etf Is Best Value by assessing cost, diversification, and proven performance across the dividend ETF landscape.
25,553 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Meta's push into cloud services could reshape AI compute bets. Learn how Nebius and CoreWeave investors might respond...
A top financial executive recently disclosed a share sale at Robinhood. This article breaks down what the move means,...
Investors are watching Nextdoor's 2025 earnings closely as the Q4 results shed light on monetization of local communi...
The Terraform Estate has filed a lawsuit in New York against Jane Street, alleging the trading firm profited from pri...
As Seer gears up for 2025 earnings, investors weigh growth, margins, and risk. This guide breaks down the drivers beh...
Power Solutions International plunged today amid a tech and energy-led market pullback. This analysis breaks down the...
A high-profile critique of a blockbuster series shines a light on how media can nudge spending habits. This article b...
Palantir reports strong government revenue growth while warning that adversaries are increasingly targeting AI data c...
A personal-finance-focused look at how the next generation must blend grit with adaptability as AI reshapes internshi...
When a director sells shares after a sharp gain, it can spark questions about the stock’s future. This article breaks...
As AI investment expands across big-cap tech and startups, ACM Research and Ouster emerge as practical additions to s...